Learn more at LeadIQ.com

Insights

Innovative Gene Therapy Technology REGENXBIO is a biotech leader with a proprietary AAV gene delivery platform, offering novel vectors like AAV7, AAV8, AAV9, and AAVrh10, presenting potential collaboration opportunities for gene therapy research and development.

Recent Key Partnerships Recent partnerships with established companies like Botox® and AbbVie showcase REGENXBIO's expansion into new therapeutic areas like retinal diseases, indicating potential avenues for cross-promotional activities and joint sales efforts.

Strategic Financial Investments Recent investments by Perceptive Advisors LLC and successful fundraising through public offerings demonstrate financial stability, presenting opportunities for investment partnerships and collaboration on future projects.

Experienced Leadership Team The addition of key personnel like Mitchell Chan as CFO and Daniel Tassé as Lead Independent Director, along with Mr. Simpson's role as Chief Technology and Operations Officer, reflects a strong leadership team providing potential channels for establishing high-level business relationships.

Market Expansion and Revenue Growth With a revenue range of $50-100M and recent financial success, including a funding of $140M, REGENXBIO demonstrates growth potential and financial health, indicating opportunities for strategic partnerships, licensing deals, and sales collaborations.

Similar companies to REGENXBIO Inc.

Passage Bio
82$10M$50M

REGENXBIO Inc. Tech Stack

REGENXBIO Inc. uses 8 technology products and services including Ultimate Software, W3 Total Cache, Microsoft Word, and more. Explore REGENXBIO Inc.'s tech stack below.

Ultimate Software
Applicant Tracking Systems
W3 Total Cache
Caching
Microsoft Word
Editors
jQuery
Javascript Libraries
CTT
Logistics
Office 365
Office Suites
JavaScript
Programming Languages
Acquia Cloud Site Factory
Web Hosting

Media & News

REGENXBIO Inc.'s Email Address Formats

REGENXBIO Inc. uses at least 1 format(s):

REGENXBIO Inc. Email Formats	Example	Percentage
FLast@regenxbio.com	JDoe@regenxbio.com	94%
Last@regenxbio.com	Doe@regenxbio.com	4%
FirstLast@regenxbio.com	JohnDoe@regenxbio.com	1%
FMiddleLast@regenxbio.com	JMichaelDoe@regenxbio.com	1%

Frequently Asked Questions

Where is REGENXBIO Inc.'s headquarters located?

REGENXBIO Inc.'s main headquarters is located at 9804 Medical Center Dr Rockville, Maryland 20850 US. The company has employees across 3 continents, including North AmericaEuropeAsia.

What is REGENXBIO Inc.'s phone number?

You can contact REGENXBIO Inc.'s main corporate office by phone at

+1-202-785-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is REGENXBIO Inc.'s stock symbol?

REGENXBIO Inc. is a publicly traded company; the company's stock symbol is RGNX.

What is REGENXBIO Inc.'s official website and social media links?

REGENXBIO Inc.'s official website is regenxbio.com and has social profiles on LinkedIn.

How much revenue does REGENXBIO Inc. generate?

As of September 2024, REGENXBIO Inc.'s annual revenue reached $75M.

What is REGENXBIO Inc.'s SIC code NAICS code?

REGENXBIO Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does REGENXBIO Inc. have currently?

As of September 2024, REGENXBIO Inc. has approximately 364 employees across 3 continents, including North AmericaEuropeAsia. Key team members include Chief Scientific Officer: O. D.Chief Medical Officer: S. P.Chief Communications & People Officer: S. F.. Explore REGENXBIO Inc.'s employee directory with LeadIQ.

What industry does REGENXBIO Inc. belong to?

REGENXBIO Inc. operates in the Biotechnology Research industry.

What technology does REGENXBIO Inc. use?

REGENXBIO Inc.'s tech stack includes Ultimate SoftwareW3 Total CacheMicrosoft WordjQueryCTTOffice 365JavaScriptAcquia Cloud Site Factory.

What is REGENXBIO Inc.'s email format?

REGENXBIO Inc.'s email format typically follows the pattern of . Find more REGENXBIO Inc. email formats with LeadIQ.

How much funding has REGENXBIO Inc. raised to date?

As of September 2024, REGENXBIO Inc. has raised $140M in funding. The last funding round occurred on Mar 06, 2024 for $140M.

When was REGENXBIO Inc. founded?

REGENXBIO Inc. was founded in 2008.

REGENXBIO Inc.

REGENXBIO Inc.

Biotechnology ResearchMaryland, United States201-500 Employees

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adeno‐associated virus (AAV) gene therapy. REGENXBIO's NAV® Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and third‐party NAV Technology Platform licensees.

Company Overview

Headquarters: 9804 Medical Center Dr Rockville, Maryland 20850 US
Phone number: ✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-202-785-****
Website: regenxbio.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: RGNX
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2008
Employees: 201-500

Media & News

Funding & Financials

$140M
REGENXBIO Inc. has raised a total of $140M of funding over 10 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $140M.
$50M$100M
REGENXBIO Inc.'s revenue is in the range of $50M$100M

Funding & Financials

$140M
REGENXBIO Inc. has raised a total of $140M of funding over 10 rounds. Their latest funding round was raised on Mar 06, 2024 in the amount of $140M.
$50M$100M
REGENXBIO Inc.'s revenue is in the range of $50M$100M

Company Leadership

O. D.
Chief Scientific Officer
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. P.
Chief Medical Officer
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. F.
Chief Communications & People Officer
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. F.
Vice President Translational And Bioanalytical Sciences [not A Promotion]
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. M.
Vice President Intellectual Property
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

L. R.
Manager Office Of The Chief Executive Officer
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. B.
Head Of Formulation And Drug Product Development
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
C. M.
Senior Vice President
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. M.
Senior Vice President, Finance
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
S. T.
Sr Vice President, Quality
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for REGENXBIO Inc. and Millions of Other Companies
Sign up for full access to REGENXBIO Inc. information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.